Complications of hydroxyapatite orbital implants in children: A series of 105 cases;Complications des implants orbitaires en hydroxyapatite chez l'enfant: A propos de 105 cas

Journal Francais d'Ophtalmologie

Volumn 23, Issue 3, 2000, Pages 249-254

  Lumbroso, L ^a   Levy, Ch ^a   Plancher, C ^a   Validire, P ^a   Asselain, B ^a   Doz, F ^a   Schlienger, P ^a   Desjardins, L ^a  

^a INSTITUT CURIE   (France)

Author keywords

Enucleation; Hydroxyapatite; Orbital implant

Indexed keywords

ARTICLE; CHILD; ENUCLEATION; EYE SURGERY; HUMAN; MAJOR CLINICAL STUDY; ORBIT IMPLANT; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; BIOCOMPATIBLE MATERIALS; CHILD; CHILD, PRESCHOOL; DURAPATITE; EVALUATION STUDIES; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; ORBITAL IMPLANTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0033993746     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Perry AC. Advances in enucleation. Ophthalmic Plast Reconstr Surg, 1991;4:173-182.
2. Shields CL, et al. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc, 1993; 91:177-195.
3. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmol, 1991;98:370-377.
4. Buettner H, and Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol, 1992;113:669-673.
5. Kim Y-D, et al. Management of exposed hydroxyapatite orbital implants. Ophthalmol, 1994;101:1709-1715.
6. Peto R, and Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc A, 1972;135:185-207.
7. Kaplan EL, and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc, 1958;53:457-481.
8. Kaltreider SA, and ANewman S. Prevention and management of complications associated with the hydroxyapatite implant. Ophthalmic Plast Reconstr Surg, 1996;12:18-31.
9. DePotter P, et al. Use of hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol, 1994;112:208-212.
10. Jordan DR, et al. The use of Vicryl mesh (Polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg, 1995;11:95-99.
11. Oestreicher JH, Liu E, and Berkowitz M. Complications of hydrohxyapatite orbital implants. Ophthalmol, 1997;104:324-329.
12. Karcioglu ZA, Al-Mesfer SA, and Mullaney PB. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmol, 1998; 105:1311-1316.
13. Nunery WR, Cepela MA, and Heinz GW. Extrusion rate of silicone spherical anophthalmic socket implants. Ophthalmic Plast Reconstr Surg, 1993;9:90-95.
14. Christmas NJ, et al. Intraorbital implants after enucleation and their complications. Arch Ophthalmol, 1998;116:1199-1203.
15. Massry GG and Holds JB. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos. Ophthalmol, 1995;102:161-166.
16. Ashworth JL, et al. A clinical study of the hydroxyapatite orbital implant. European Journal Ophthalmology, 1997;7:1-8.
17. Martin P, and Gabrial R. Repair of exposed hydroxyapatite orbital implant by a tarsoconjunctival pedicle flap. Ophthalmol, 1998; 105:1694-1697.
18. Nunery WR, et al. Exposure rate of hydroxyapatite sheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconst Surg, 1993;9:96-104.